{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T08:50:42Z","timestamp":1660121442513},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T00:00:00Z","timestamp":1389225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2393-14-10","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T14:01:30Z","timestamp":1389276090000},"source":"Crossref","is-referenced-by-count":4,"title":["Prioritizing investments in innovations to protect women from the leading causes of maternal death"],"prefix":"10.1186","volume":"14","author":[{"given":"Tara M","family":"Herrick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia M","family":"Harner-Jay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice M","family":"Levisay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia S","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Free","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D","family":"LaBarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"898_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(12)61127-1","volume":"380","author":"P Howett","year":"2012","unstructured":"Howett P, Darzi A, Yang G-Z, et al: Technologies for global health. Lancet. 2012, 380: 507-535. 10.1016\/S0140-6736(12)61127-1.","journal-title":"Lancet"},{"issue":"9","key":"898_CR2","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMp1108040","volume":"365","author":"SR Sinha","year":"2011","unstructured":"Sinha SR, Barry M: Health technologies and innovation in the global health arena. N Engl J Med. 2011, 365 (9): 779-782. 10.1056\/NEJMp1108040.","journal-title":"N Engl J Med"},{"key":"898_CR3","volume-title":"Trends in Maternal Mortality: 1990 to 2010","author":"World Health Organization (WHO)","year":"2012","unstructured":"World Health Organization (WHO): Trends in Maternal Mortality: 1990 to 2010. 2012, Geneva: WHO"},{"key":"898_CR4","doi-asserted-by":"crossref","DOI":"10.18356\/32f1e244-en","volume-title":"Millennium Development Goals Report 2012","author":"U Nations","year":"2012","unstructured":"Nations U: Millennium Development Goals Report 2012. 2012, New York: United Nations"},{"key":"898_CR5","doi-asserted-by":"publisher","first-page":"d7023","DOI":"10.1136\/bmj.d7023","volume":"343","author":"JD Shelton","year":"2011","unstructured":"Shelton JD: Twenty criteria to make the best of scarce health resources in developing countries. BMJ. 2011, 343: d7023-10.1136\/bmj.d7023.","journal-title":"BMJ"},{"key":"898_CR6","volume-title":"Commissioners\u2019 Report September 2012","author":"United Nations Commission on Life-Saving Commodities for Women and Children","year":"2012","unstructured":"United Nations Commission on Life-Saving Commodities for Women and Children: Commissioners\u2019 Report September 2012. 2012, New York: United Nations"},{"key":"898_CR7","volume-title":"Public private partnership for the development of heat-stable oxytocin","author":"MDG5 Meshwork for Improving Maternal Health","year":"2010","unstructured":"MDG5 Meshwork for Improving Maternal Health: Public private partnership for the development of heat-stable oxytocin. 2010, Available at: http:\/\/www.mdg5-meshwork.org\/content\/public-private-partnership-development-heat-stable-oxytocin . Accessed 4 December 2012"},{"key":"898_CR8","volume-title":"Guidelines for the Management of Postpartum Haemorrhage and Retained Placenta","author":"World Health Organization (WHO)","year":"2012","unstructured":"World Health Organization (WHO): Guidelines for the Management of Postpartum Haemorrhage and Retained Placenta. 2012, Geneva: WHO, Available at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/75411\/1\/9789241548502_eng.pdf . Accessed 7 December 2012"},{"key":"898_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/00016340802179822","volume":"87","author":"SK Doumouchtsis","year":"2008","unstructured":"Doumouchtsis SK, Papageorghiou AT, Vernier C, Arulkumaran S: Management of postpartum hemorrhage by uterine balloon tamponade: prospective evaluation of effectiveness. Acta Obstet Gynecol Scand. 2008, 87: 849-855. 10.1080\/00016340802179822.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"898_CR10","volume-title":"BJOG","author":"K Tindell","year":"2012","unstructured":"Tindell K, Garfinkel R, Abu-Haydar E, et al: Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG. 2012, doi:10.1111\/j.1471-0528.2012.03454.x. [Epub ahead of print]"},{"key":"898_CR11","volume-title":"WHO Recommendations for the Prevention and Treatment of Preeclampsia and Eclampsia","author":"World Health Organization (WHO)","year":"2011","unstructured":"World Health Organization (WHO): WHO Recommendations for the Prevention and Treatment of Preeclampsia and Eclampsia. 2011, Geneva: WHO"},{"issue":"21","key":"898_CR12","first-page":"113","volume":"10","author":"G Dhakal","year":"2012","unstructured":"Dhakal G, Subedi M, Paudel K: Magnesium sulphate in management of severe pre-eclampsia and eclampsia. J Nepal Health Res Counc. 2012, 10 (21): 113-117.","journal-title":"J Nepal Health Res Counc"},{"key":"898_CR13","volume-title":"J Pregnancy","author":"KO Osungbade","year":"2011","unstructured":"Osungbade KO, Ige OK: Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011, 481095: doi: 10.1155\/2011\/481095"},{"key":"898_CR14","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.ijgo.2004.03.009","volume":"85","author":"J Villar","year":"2004","unstructured":"Villar J, Say L, Shennan A, et al: Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of preeclampsia and eclampsia. Int J Gynaecol Obstet. 2004, 85: S28-S41.","journal-title":"Int J Gynaecol Obstet"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-14-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2393-14-10\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-14-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T02:48:02Z","timestamp":1565059682000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/1471-2393-14-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,9]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["898"],"URL":"https:\/\/doi.org\/10.1186\/1471-2393-14-10","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,9]]},"article-number":"10"}}